AstraZeneca | Investor Conference Presentation Deck

Slide schematic 9/9

list 7/7 title 2/2

Components 9

bullet bullet bullet bullet bullet bullet bullet action-title headline

Tools 1

list/bullet: Delivering continued oncology leadership: Tumour area leadership with current medicines as established SoC; Proven track record in increasingly competitive markets; Limited LoE exposure through 2030

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

The slide uses a structured layout to present the company's oncology portfolio, categorizing drugs by their therapeutic focus and market position.